TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Zoono Group Limited ( (AU:ZNO) ).
Zoono Group Limited has concluded its non-renounceable rights issue, raising approximately $785,005.55, with a significant portion of shares subscribed by the Managing Director, Paul Hyslop. The funds will support projects like supermarket shelf-life extension, expansion into China and India, debt repayment, and intellectual property protection. The remaining shares will be offered in a Shortfall Offer, open for three months, to further bolster the company’s financial position and strategic initiatives.
More about Zoono Group Limited
Zoono Group Limited is a global biotech company that specializes in developing, manufacturing, and distributing environmentally-friendly antimicrobial solutions. Their product range includes sprays, wipes, and foams for skin care, surface sanitization, and mould remediation, all based on a unique antimicrobial molecule. Headquartered in New Zealand, Zoono’s products are available worldwide and have received various regulatory approvals supported by independent testing.
Average Trading Volume: 603,072
Technical Sentiment Signal: Sell
Current Market Cap: A$11.37M
Find detailed analytics on ZNO stock on TipRanks’ Stock Analysis page.